Guardian Capital (Canada)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Guardian Capital (Canada)'s GILD Position: Q3 2019 in Review
Guardian Capital (Canada) sold out of Gilead Sciences (GILD) in Q3 2019, closing a stake of 5,272 shares — an estimated $356K sold.
Guardian Capital (Canada) first reported a position in GILD in Q2 2014 and held it in 15 quarters. The position peaked at $11.1M in Q4 2015. 1,462 funds tracked by Wall St. Rank hold GILD as of Q3 2019.
- Guardian Capital (Canada) reported no remaining Gilead Sciences position as of Q3 2019 after selling out during the quarter.
- Guardian Capital (Canada) sold 5,272 Gilead Sciences shares in Q3 2019, an estimated $356K.
- Guardian Capital (Canada) first reported a position in Gilead Sciences in Q2 2014 and held it in 15 quarters.
- Guardian Capital (Canada)'s Gilead Sciences position peaked at $11.1M in Q4 2015.
- 1,462 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.
Based on Guardian Capital (Canada)'s 13F filing for Q3 2019, filed 14 Nov 2019.